We are live on
!
Find out more
Plus Therapeutics
PSTV
PSTV
16 hedge funds and large institutions have $588K invested in Plus Therapeutics in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
0.01% less ownership
Funds ownership: 0.02% → 0.02% (-0.01%)
27% less funds holding
Funds holding: 22 → 16 (-6)
33% less capital invested
Capital invested by funds: $872K → $588K (-$284K)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
86% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 7
Holders
16
Holders Change
-6
Holders Change %
-27.27%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
4
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$66.7K |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$9.15K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$673 |
Top Sellers
| 1 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$185K |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
-$60.4K |
| 3 |
Millennium Management
New York
|
-$24.1K |
| 4 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
-$7.92K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$6.86K |
